• OPEN AN ACCOUNT
Indian Indices
Nifty
22,475.85 -172.35
(-0.76%)
Sensex
73,895.54 17.39
( 0.02%)
Bank Nifty
48,923.55 -307.50
( -0.62%)
Nifty IT
32,908.40 -294.95
( -0.89%)
Global Indices
Nasdaq
16,156.33 315.37
(1.99%)
Dow Jones
38,675.68 450.02
(1.18%)
Hang Seng
18,578.30 102.38
(0.55%)
Nikkei 225
38,236.07 -37.98
(-0.10%)
Forex
USD-INR
83.43 -0.03
(-0.04%)
EUR-INR
89.37 0.26
(0.29%)
GBP-INR
104.48 0.21
(0.20%)
JPY-INR
0.54 0.01
(1.69%)

EQUITY - MARKET SCREENER

FDC Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
531599
INE258B01022
121.05335
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FDC
24.68
7308.54
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0
 

Laurus Labs consolidated net profit declines 26.58% in the March 2024 quarter
Apr 25,2024
Net profit of Laurus Labs declined 26.58% to Rs 75.61 crore in the quarter ended March 2024 as against Rs 102.98 crore during the previous quarter ended March 2023. Sales rose 4.26% to Rs 1439.67 crore in the quarter ended March 2024 as against Rs 1380.90 crore during the previous quarter ended March 2023.

For the full year,net profit declined 79.68% to Rs 160.55 crore in the year ended March 2024 as against Rs 790.11 crore during the previous year ended March 2023. Sales declined 16.55% to Rs 5040.83 crore in the year ended March 2024 as against Rs 6040.55 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1439.671380.90 4 5040.836040.55 -17
OPM %16.7720.68 -15.4226.36 -
PBDT209.52234.15 -11 620.941433.02 -57
PBT107.27147.14 -27 236.361108.94 -79
NP75.61102.98 -27 160.55790.11 -80